Special Populations-Reference-Cited by-同舟云学术

Special Populations

Published:2009-06 Issue: Volume:10 Page:21-22
ISSN:1526-0542
Container-title:Paediatric Respiratory Reviews
language:en
Short-container-title:Paediatric Respiratory Reviews

Author:

Fauroux Brigitte

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Pediatrics, Perinatology and Child Health

Reference20 articles.

1. Role of respiratory pathogens in infants hospitalised for a first episode of wheezing and their impact on recurrences;Bosis;Clin Microbiol Infect,2008

2. Recent trends in severe respiratory syncytial virus (RSV) among US infants, 1997 to 2000;Leader;J Pediatr,2003

3. The burden of respiratory syncytial virus infection in young children;Hall;N Engl J Med,2009

4. Rates of hospitalisation for respiratory syncytial virus infection among children in Medicaid;Boyce;J Pediatr,2000

5. Respiratory syncytial virus and premature infants born at 32 weeks' gestation or earlier: hospitalisation and economic implications of prophylaxis;Stevens;Arch Pediatr Adolesc Med,2000

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Delivery of ALX-0171 by inhalation greatly reduces respiratory syncytial virus disease in newborn lambs;mAbs;2018-05-07

2. Exacerbación Del Asma Con Sibilancias Y Desencadenada Por Infección: ¿Es Posible La Prevención a Una Edad Temprana?;EMJ Respiratory;2017-12-22

3. Wheezing and Infection-Triggered Asthma Exacerbation: Is Prevention in Early Childhood Possible?;EMJ Respiratory;2017-12-11

4. Nanobodies® † †Nanobody is a registered trademark of Ablynx NV. as inhaled biotherapeutics for lung diseases;Pharmacology & Therapeutics;2017-01

5. Efficacy, Safety, and Pharmacokinetics of a New 10 % Liquid Intravenous Immunoglobulin Containing High Titer Neutralizing Antibody to RSV and Other Respiratory Viruses in Subjects with Primary Immunodeficiency Disease;Journal of Clinical Immunology;2016-06-20